We are live on ! Find out more
DMII

Drugs Made In America Acquisition II Corp
DMII

68 hedge funds and large institutions have $438M invested in Drugs Made In America Acquisition II Corp in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 2

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

33% more funds holding

Funds holding: 51 → 68 (+17)

28% more capital invested

Capital invested by funds: $343M → $438M (+$95.2M)

14.45% more ownership

Funds ownership: 54.51% → 68.96% (+14%)

27% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 15

Holders
68
Holders Change
+17
Holders Change %
+33.33%
% of All Funds
0.84%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
19
Increased
11
Reduced
15
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
+$26.9M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$19.9M
3
KIM
Karpus Investment Management
New York
+$14.5M
4
MCS
Mercuria Capital Strategies
Texas
+$7.47M
5
WAM
Wolverine Asset Management
Illinois
+$7.3M

Top Sellers

Rank Fund Capital Flow
1
FTCM
First Trust Capital Management
Illinois
-$9.97M
2
CL
CSS LLC
Illinois
-$6.93M
3
MSU
Mizuho Securities USA
New York
-$1.97M
4
CS
Clear Street
New York
-$1.66M
5
CCC
Cable Car Capital
California
-$990K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
26
Heights Capital Management
California
$5.18M +$5.17M +519,400 New
WCMNY
27
Westchester Capital Management (New York)
New York
$4.99M +$60 +6 +0%
BCM
28
BlueCrest Capital Management
Jersey
$4.99M +$4.98M +500,000 New
HI
29
HBK Investments
Texas
$4.99M – – –
SC
30
Sculptor Capital
New York
$4.99M – – –
SAMU
31
SONA Asset Management (US)
New York
$4.99M +$1.99M +200,000 +67%
WA
32
Whitebox Advisors
Minnesota
$4.49M – – –
SCM
33
Shaolin Capital Management
Florida
$4.24M – – –
WC
34
Wealthspring Capital
New York
$4.01M -$62.6K -6,280 -2%
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$3.94M +$462K +46,350 +13%
CA
36
Crossingbridge Advisors
New York
$3.49M +$3.49M +350,000 New
COPPSERS
37
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$3.49M -$498K -50,000 -13%
LPC
38
Lineage Point Capital
Florida
$3.35M – – –
KC
39
Kryger Capital
United Kingdom
$3.09M +$3.09M +309,729 New
RCM
40
Rivernorth Capital Management
Florida
$2.99M +$2.99M +300,000 New
MTCM
41
Mint Tower Capital Management
Netherlands
$2.49M – – –
HCM
42
Highbridge Capital Management
New York
$2.25M +$2.24M +225,004 New
PC
43
Periscope Capital
Ontario, Canada
$2.24M -$403K -40,500 -15%
Verition Fund Management
44
Verition Fund Management
Connecticut
$2.02M +$28.3K +2,840 +1%
GCIA
45
Gabelli & Co Investment Advisers
New York
$1.79M +$1.79M +179,500 New
GF
46
Gabelli Funds
New York
$1.61M +$1.61M +161,400 New
Parallax Volatility Advisers
47
Parallax Volatility Advisers
California
$1.34M +$1.33M +133,647 New
JP Morgan Chase
48
JP Morgan Chase
New York
$1.29M – – –
SSA
49
Schonfeld Strategic Advisors
New York
$1.12M +$1.12M +112,323 New
DAM
50
DLD Asset Management
New York
$1.11M -$6.9K -693 -0.6%
1
2
3

DMII Hedge Fund Activity: Q1 2026 in Review

68 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp (DMII) for Q1 2026, worth a combined $438M — up 28% from $343M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new DMII positions and 2 closed out — a net gain of 17 holders — while 11 added to existing stakes and 15 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $26.9M. The largest seller was First Trust Capital Management, cutting an estimated $9.97M.

  • 68 institutional investors held Drugs Made In America Acquisition II Corp (DMII) as of Q1 2026, up from 51 in Q4 2025.
  • Funds reported $438M of Drugs Made In America Acquisition II Corp stock for Q1 2026, up 28% quarter-over-quarter.
  • 19 funds opened new Drugs Made In America Acquisition II Corp positions in Q1 2026 and 2 closed out, a net change of +17 holders.
  • The largest Drugs Made In America Acquisition II Corp buyer in Q1 2026 was MMCAP International, an estimated $26.9M added.
  • The largest Drugs Made In America Acquisition II Corp seller in Q1 2026 was First Trust Capital Management, an estimated $9.97M sold.

Based on aggregated 13F filings for Q1 2026.